Atrás
Rango del Día
$16.26
$16.29
Rango de 52 Semanas
$11.65
$18.61
Volumen
1,855,631
Promedio 50D / 200D
$15.60
/
$14.35
Cierre Anterior
$16.25
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 13.8 | 0.4 |
| P/B | 1.2 | 2.9 |
| ROE % | 8.6 | 3.8 |
| Net Margin % | 2.7 | 3.9 |
| Rev Growth 5Y % | -3.2 | 10.0 |
| D/E | 2.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$18.00
+10.6%
Low: $17.00
High: $19.00
P/E Futuro
12.9
EPS Futuro
$1.26
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
5.7 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$1.51
$1.23 – $1.78
|
6.2 B | 2 |
| FY2027 |
$1.39
$1.30 – $1.45
|
6 B | 4 |
| FY2026 |
$1.26
$1.24 – $1.29
|
5.7 B | 4 |
Puntos Clave
Revenue declined -3.18% annually over 5 years
Earnings declined -31.69% over the past year
Debt/Equity of 2.17 — high leverage
Generating 382.74M in free cash flow
P/E of 13.80 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.30%
Crecimiento
Revenue Growth (5Y)
-3.18%
Revenue (1Y)5.12%
Earnings (1Y)-31.69%
FCF Growth (3Y)4.15%
Calidad
Return on Equity
8.63%
ROIC4.64%
Net Margin2.68%
Op. Margin6.14%
Seguridad
Debt / Equity
2.17
Current Ratio1.04
Interest Coverage2.85
Valoración
P/E Ratio
13.80
P/B Ratio1.18
EV/EBITDA17.02
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.12% | Revenue Growth (3Y) | -9.54% |
| Earnings Growth (1Y) | -31.69% | Earnings Growth (3Y) | -22.51% |
| Revenue Growth (5Y) | -3.18% | Earnings Growth (5Y) | -22.35% |
| Profitability | |||
| Revenue (TTM) | 5.45B | Net Income (TTM) | 146.22M |
| ROE | 8.63% | ROA | 2.50% |
| Gross Margin | 11.54% | Operating Margin | 6.14% |
| Net Margin | 2.68% | Free Cash Flow (TTM) | 382.74M |
| ROIC | 4.64% | FCF Growth (3Y) | 4.15% |
| Safety | |||
| Debt / Equity | 2.17 | Current Ratio | 1.04 |
| Interest Coverage | 2.85 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 13.80 | P/B Ratio | 1.18 |
| P/S Ratio | 0.37 | PEG Ratio | -0.43 |
| EV/EBITDA | 17.02 | Dividend Yield | 0.02% |
| Market Cap | 2.02B | Enterprise Value | 5.70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.45B | 5.19B | 6.66B | 6.33B | 6.20B |
| Net Income | 146.22M | 214.04M | 243.49M | 158.99M | 402.23M |
| EPS (Diluted) | 1.18 | 1.66 | 1.91 | 1.23 | 2.99 |
| Gross Profit | 629.30M | 633.64M | 932.04M | 733.38M | 919.37M |
| Operating Income | 334.58M | 268.32M | 554.87M | 403.28M | 713.77M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.85B | 5.61B | 7.69B | 7.67B | 7.36B |
| Total Liabilities | 3.82B | 3.61B | 6.12B | 6.27B | 6.00B |
| Shareholders' Equity | 1.71B | 1.68B | 1.29B | 1.12B | 1.11B |
| Total Debt | 3.70B | 2.70B | 4.52B | 5.16B | 4.76B |
| Cash & Equivalents | 26.52M | 59.69M | 52.63M | 97.91M | 74.31M |
| Current Assets | 1.03B | 1.02B | 1.26B | 1.27B | 1.14B |
| Current Liabilities | 984.49M | 977.65M | 1.25B | 1.16B | 1.27B |